Exosomal miRNAs as biomarkers of recurrent lung cancer
Prognosis of lung cancer still remains grim largely due to recurrence and aggressive metastasis of the disease. In this study, we examined the potential of exosomal miRNAs as biomarkers of recurrent lung cancer. Initially, in vitro miRNA profiles of normal lung (Beas-2b) and lung cancer (H1299) cells and of exosomes isolated from conditioned media were determined. In vivo study involved establishing subcutaneous primary and recurrent lung cancer xenografts in nude mouse model and examining tumor and serum exosomal miRNA alteration in secondary/recurrent lung tumors. A total of 77 miRNAs were observed to be significantly modulated in the H1299 cells (47 miRNA upregulated and 30 downregulated) compared to the Beas-2b cells. The exosomes isolated from conditioned media indicated several miRNAs which were in agreement with cells of origin. A similarity was also observed between miRNAs from serum exosomes and tumors, indicating their origin from the lung tumors. Two miRNAs, miR-21 and miR-155, were found to be significantly upregulated in recurrent tumors compared to primary tumors. These miRNAs were also upregulated in serum exosomes of recurrent tumor-bearing animals versus non-tumor- or primary tumor-bearing animals. Increased expression of the recurrent disease markers were also observed in recurrent tumors compared with primary tumors. Serum exosomes from recurrent tumor mice mirrored its tumor profile in expressing higher levels of these proteins compared with exosomes from primary tumor mice. Our data suggest that exosomal miRNA signatures may be a true representation of a pathological profile of lung cancer; thus, miRNAs could serve as promising biomarkers for non-invasive diagnosis of the disease.
KeywordsExosomes miRNA Lung cancer Recurrent lung tumors Biomarker
This work was supported from the Agnes Brown Duggan Endowment and Helmsley Trust Funds. Ramesh C. Gupta holds the Agnes Brown Duggan Chair in Oncological Research. The Microarray core is gratefully acknowledged for assisting with sample analysis and Xiaohong Li, Biostatistician, University of Louisville Bioinformatics Core, for her assistance in analysis of the data. We thank Manicka V. Vadhanam for useful discussions during the study.
- 1.American Cancer Society. Cancer Facts & Figures 2012.Google Scholar
- 2.Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF et al. SEER Cancer Statistics Review, 1975–2012. National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2012/. based on November 2014 SEER data submission, posted to the SEER web site, April 2015.
- 5.Roma-Rodrigues C, Fernandes AR, Baptista PV. Exosome in Tumour Microenvironment: Overview of the Crosstalk between Normal and Cancer Cells. Biomed Res Int. 2014. doi:Artn 179486 10.1155/2014/179486.
- 6.Peinado H, Aleckovic M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med. 2012;18(6):883−+. doi: 10.1038/nm.2753.
- 19.Hornick NI, Huan J, Doron B, Goloviznina NA, Lapidus J, Chang BH et al. Serum Exosome MicroRNA as a Minimally-Invasive Early Biomarker of AML. Sci Rep-Uk. 2015;5. doi:Artn 11295 10.1038/Srep11295.
- 20.Ogata-Kawata H, Izumiya M, Kurioka D, Honma Y, Yamada Y, Furuta K et al. Circulating Exosomal microRNAs as Biomarkers of Colon Cancer. PloS one. 2014;9(4). doi:ARTN e92921 10.1371/journal.pone.0092921.
- 21.Tokuhisa M, Ichikawa Y, Kosaka N, Ochiya T, Yashiro M, Hirakawa K et al. Exosomal miRNAs from Peritoneum Lavage Fluid as Potential Prognostic Biomarkers of Peritoneal Metastasis in Gastric Cancer. PloS one. 2015;10(7). doi:ARTN e0130472 10.1371/journal.pone.0130472.
- 30.Saito M, Schetter AJ, Mollerup S, Kohno T, Skaug V, Bowman ED, et al. The association of microRNA expression with prognosis and progression in early-stage, non-small cell lung adenocarcinoma: a retrospective analysis of three cohorts. Clin Cancer Res. 2011;17(7):1875–82. doi: 10.1158/1078-0432.CCR-10-2961.CrossRefPubMedPubMedCentralGoogle Scholar
- 33.Huang LL, Wang XY, Wen CY, Yang XL, Song MM, Chen JX et al. Hsa-miR-19a is associated with lymph metastasis and mediates the TNF-alpha induced epithelial-to-mesenchymal transition in colorectal cancer. Sci Rep-Uk. 2015;5. doi:Artn 13350 10.1038/Srep13350.
- 36.D'Amico TA, Massey M, Herndon JE, Moore MB, Harpole DH. A biologic risk model for stage I lung cancer: Immunohistochemical analysis of 408 patients with the use of ten molecular markers. J Thorac Cardiov Sur. 1999;117(4):736–42. doi:Doi 10.1016/S0022-5223(99)70294-1.
- 37.Sterlacci W, Fiegl M, Hilbe W, Jamnig H, Oberaigner W, Schmid T, et al. Deregulation of p27 and Cyclin D1/D3 control over mitosis is associated with unfavorable prognosis in non-small cell lung cancer, as determined in 405 operated patients. J Thorac Oncol. 2010;5(9):1325–36.CrossRefPubMedGoogle Scholar
- 42.Dworakowska D, Jassem E, Jassem J, Boltze C, Wiedorn KH, Dworakowski R, et al. Prognostic value of cyclin D1 overexpression in correlation with pRb and p53 status in non-small cell lung cancer (NSCLC). J Cancer Res Clin Oncol. 2005;131(7):479–85. doi: 10.1007/s00432-004-0661-9.CrossRefPubMedGoogle Scholar
- 43.Dworakowska D, Jassem E, Jassem J, Karmolinski A, Lapinski M, Tomaszewski D, et al. Prognostic value of the apoptotic index analysed jointly with selected cell cycle regulators and proliferation markers in non-small cell lung cancer. Lung Cancer. 2009;66(1):127–33. doi: 10.1016/j.lungcan.2009.01.008.CrossRefPubMedGoogle Scholar
- 50.Thery C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Current protocols in cell biology / editorial board, Juan S Bonifacino [et al.]. 2006;Chapter 3:Unit 3 22. doi: 10.1002/0471143030.cb0322s30.